Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) (vol 51, 80, 2023)
UROLITHIASIS(2023)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined